Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
- PMID: 26104564
- PMCID: PMC8162739
- DOI: 10.1128/microbiolspec.AID-0027-2014
Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
Abstract
The human hybridoma technique offers an important approach for isolation of human monoclonal antibodies. A diversity of approaches can be used with varying success. Recent technical advances in expanding the starting number of human antigen-specific B cells, improving fusion efficiency, and isolating new myeloma partners and new cell cloning methods have enabled the development of protocols that make the isolation of human monoclonal antibodies from blood samples feasible. Undoubtedly, additional innovations that could improve efficiency are possible.
Conflict of interest statement
Conflicts of interest: We disclose no conflicts.
Figures
Similar articles
-
Hybridoma technologies for antibody production.Immunotherapy. 2011 Mar;3(3):371-80. doi: 10.2217/imt.11.4. Immunotherapy. 2011. PMID: 21395379 Review.
-
Preparation of human-mouse heterohybridomas against an immunising antigen.J Immunol Methods. 2000 Dec 1;246(1-2):187-202. doi: 10.1016/s0022-1759(00)00293-3. J Immunol Methods. 2000. PMID: 11121559
-
Generation of Murine Monoclonal Antibodies by Hybridoma Technology.J Vis Exp. 2017 Jan 2;(119):54832. doi: 10.3791/54832. J Vis Exp. 2017. PMID: 28117810 Free PMC article.
-
Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.Hybridoma (Larchmt). 2006 Oct;25(5):283-92. doi: 10.1089/hyb.2006.25.283. Hybridoma (Larchmt). 2006. PMID: 17044784
-
Antibody engineering, a strategy for the development of monoclonal antibodies.Antonie Van Leeuwenhoek. 1984;50(5-6):597-623. doi: 10.1007/BF02386229. Antonie Van Leeuwenhoek. 1984. PMID: 6099095 Review.
Cited by
-
Precision engineering for localization, validation, and modification of allergenic epitopes.J Allergy Clin Immunol. 2024 Mar;153(3):560-571. doi: 10.1016/j.jaci.2023.12.017. Epub 2024 Jan 3. J Allergy Clin Immunol. 2024. PMID: 38181840 Review.
-
Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections.Viruses. 2023 Oct 30;15(11):2177. doi: 10.3390/v15112177. Viruses. 2023. PMID: 38005854 Free PMC article. Review.
-
Engineering therapeutic monoclonal antibodies.J Allergy Clin Immunol. 2024 Mar;153(3):539-548. doi: 10.1016/j.jaci.2023.11.018. Epub 2023 Nov 21. J Allergy Clin Immunol. 2024. PMID: 37995859 Review.
-
Biodistribution and function of coupled polymer-DNA origami nanostructures.Sci Rep. 2023 Nov 10;13(1):19567. doi: 10.1038/s41598-023-46351-1. Sci Rep. 2023. PMID: 37949918 Free PMC article.
-
Isolation, cloning and analysis of parvovirus-specific canine antibodies from peripheral blood B cells.Dev Comp Immunol. 2023 Oct;147:104894. doi: 10.1016/j.dci.2023.104894. Epub 2023 Jul 17. Dev Comp Immunol. 2023. PMID: 37467826 Free PMC article.
References
-
- Kohler G, Milstein C. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497. - PubMed
-
- Schwaber J, Cohen EP. 1973. Human × mouse somatic cell hybrid clone secreting immunoglobulins of both parental types. Nature 244:444–447. - PubMed
-
- Stevens RH, Macy E, Morrow C, Saxon A. 1979. Characterization of a circulating subpopulation of spontaneous anti-tetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol 122:2498–2504. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources